Ocean Biomedical, Inc. (OCEA)
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases i...
- Open
- 0.0008
- High
- 0.0008
- Low
- 0.0001
- Prev. Close
- 0.0008
- Volume
- 92.55K
- Turnover
- 73.07
- Avg Price
- 0.0008
- Bid/Ask Ratio
- --
- Amplitude
- 87.50%
- 52wk High
- 0.0072
- Volume Ratio
- 10.47
- Turnover Ratio
- 0.04%
Ocean Biomedical, Inc. Analyst Rating
View moreForecast & Rating
Apr 1, 2024Price forecast
$18.502312400.00%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- TradingView · Apr 8 at 01:13 PM
Odyssey Marine to Merge With American Ocean Minerals; Raises $156M PIPE, Sets Asset Spinoff
- Tip Ranks · Apr 8 at 07:13 AM
Ondine Study on ICU Nasal Photodisinfection Wins Acceptance in Journal of Critical Care
- Tip Ranks · Apr 3 at 06:00 PM
Zaggle CFO Resigns; Board Names Interim Finance Chief
- biopharmadive · Apr 3 at 03:40 PM
Immunovant eye drug flunks Phase 3 studies; Beam sickle cell data published in NEJM
- Tip Ranks · Apr 1 at 08:39 AM
Oceana Metals Options Lapse, Trimming Potential Share Dilution
- Tip Ranks · Apr 1 at 08:39 AM
Oceana Metals Seeks ASX Quotation for Nearly 295,000 New Shares
